Effect of Varying Levels of Disease Management on Smoking Cessation
- 7 April 2009
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 150 (7), 437-446
- https://doi.org/10.7326/0003-4819-150-7-200904070-00003
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Design and baseline characteristics from the KAN-QUIT disease management intervention for rural smokers in primary carePreventive Medicine, 2008
- Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapyAddiction, 2003
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- Does the Chronic Care Model Serve Also as a Template for Improving Prevention?The Milbank Quarterly, 2001
- Tailoring tobacco counseling to the competing demands in the clinical encounter.2001
- Direct observation of smoking cessation activities in primary care practice.2001
- Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled studyClinical Pharmacology & Therapeutics, 2001
- The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change.Journal of Consulting and Clinical Psychology, 1991
- Models for Longitudinal Data: A Generalized Estimating Equation ApproachBiometrics, 1988
- Optimum cutoff points for biochemical validation of smoking status.American Journal of Public Health, 1988